Oral JAK Inhibitors | Uses |
Abrocitinib | Atopic eczema |
Baricitinib | Atopic eczema, rheumatoid arthritis |
Tofacitinib | Rheumatoid arthritis, psoriatic arthritis and ulcerative colitis |
Upadacitinib | Atopic eczema, rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis |
Common side effects include:
Side effects | Warning signs |
Allergic reaction |
|
Infection |
|
Increase in muscle enzymes |
|
Liver problems |
|
Stomach problems (applicable to Baricitinib, Tofacitinib and Upadacitinib only) |
|
Heart problems, stroke, blood clots |
|
Heart problems, stroke, blood clots |
|
Blood disorders |
|
Cancer or malignancy |
|
Disclaimers
If you take more than the recommended dose, please seek medical advice immediately. The information provided on this page does not replace information from your healthcare professional. Please consult your healthcare professional for more information.
This article is jointly developed by members of the National Medication Information workgroup. The workgroup consists of cluster partners (National Healthcare Group, National University Health System, and SingHealth), community pharmacies (Guardian, Unity, and Watsons), and the Pharmaceutical Society of Singapore. The content does not reflect drug availability and supply information in pharmacies and healthcare institutions. You are advised to check with the respective institutions for such information.
Last Updated on October 2022
Use Medicine Order Service on HealthBuddy.
Get reminders and chart progress on HealthBuddy.